Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 2, 2007

Roche Strengthens Antibody Research with $56.5M Acquisition

  • Roche paid $56.5 million for antibody technology company Therapeutic Human Polyclonals (THP). The company reports that the acquisition strengthens its expertise in therapeutic antibody research.

    Roche plans to fully integrate THP into the Roche Pharma Center of Excellence for Protein Research organization in Penzberg, Germany.

    A California-based company with a subsidiary in Germany, THP is focused on research in human antibody technologies. The company has developed a transgenic mammalian platform to create human antibodies. Roche reports that this technology will enable it to generate monoclonal and polyclonal antibody therapeutics with enhanced efficacy.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »